Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: Specificity, sensitivity, and a possible prognostic value

Amyotrophic Lateral Sclerosis

Volumn 12, Issue 2, 2011, Pages 140-143

  Noto, Yu Ichi ^a,b   Shibuya, Kazumoto ^a   Sato, Yasunori ^c   Kanai, Kazuaki ^a   Misawa, Sonoko ^a   Sawai, Setsu ^a   Mori, Masahiro ^a   Uchiyama, Tomoyuki ^a   Isose, Sagiri ^a   Nasu, Saiko ^a   Sekiguchi, Yukari ^a   Fujimaki, Yumi ^a,d   Kasai, Takashi ^b   Tokuda, Takahiko ^b   Nakagawa, Masanori ^b   Kuwabara, Satoshi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c CHIBA UNIVERSITY HOSPITAL   (Japan)

^d TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

Author keywords

Amyotrophic lateral sclerosis; cerebrospinal fluid (CSF); ELISA; TAR DNA binding protein of 43 kDa (TDP 43)

Indexed keywords

BIOLOGICAL MARKER; TAR DNA BINDING PROTEIN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; MALE; MULTIPLE SCLEROSIS; PARKINSON DISEASE; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL TIME;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MARKERS; DNA-BINDING PROTEINS; HUMANS; INFLAMMATION; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; PROGNOSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 79951764734     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482968.2010.541263     Document Type: Article

References (10)

1. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602-11. (Pubitemid 44708852)
2. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130-3. (Pubitemid 44547757)
3. Kasai T, Tokuda T, Ishigami N, Sasayama H, Foulds P, Mitchell DJ, et al. Increased TDP-43 protein in cerebrospinal fl uid of patients with amyotrophic lateral sclerosis. Acta Neuropathol. 2009;117:55-62.
4. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293-9.
5. de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119:497-503.
6. Steinacker P, Hendrich C, Sperfeld AD, Jesse S, von Arnim CA, Lehnert S, et al. TDP-43 in cerebrospinal fl uid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch Neurol. 2008;65:1481-7.
7. Geser F, Lee VM, Trojanowski JQ. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies. Neuropathology. 2010;30:103-12.
8. Sussmuth SD, Sperfeld AD, Hinz A, Brettschneider J, Endruhn S, Ludolph AC, et al. CSF glial markers correlate with survival in amyotrophic lateral sclerosis. Neurology. 2010;74:982-7.
9. FialováL, SvarcováJ, Bartos A, Ridzon P, Malbohan I, Keller O, et al. Cerebrospinal fl uid and serum antibodies against neurofi laments in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2010;17:562-6.
10. Ryberg H, An J, Darko S, Lustgarten JL, Jaffa M, Gopalakrishnan V, et al. Discovery and verifi cation of amyotrophic lateral sclerosis biomarkers by proteomics. Muscle Nerve. 2010;42:104-11.